News -CureApp, Inc.

We are pleased to inform you that the article has been published with the approval of our Nicotine Addiction Treatment App With CO Checker.   Bio Space Asia’s First Prescription “Digital Therapeutic” Approved in Japan; Nicotine Addiction Treatment App With CO Checker Receives Regulatory Approval - CureApp, Inc.   https://www.biospace.com/article/releases/asia-s-first-prescription-digital-therapeutic-approved-in-japan-nicotine-addiction-treatment-app-with-co-checker-receives-regulatory-approval-cureapp-inc-/?s=85&utm_source=dlvr.it&utm_medium=twitter

CureApp will begin clinical research using a therapeutic application dedicated to NASH (Non-Alcoholic Steatohepatitis) developed in collaboration with the Department of Gastroenterology of the University of Tokyo Hospital. CureApp will begin clinical research using a therapeutic application dedicated to NASH (Non-Alcoholic Steatohepatitis) developed in collaboration with the Department of Gastroenterology of the University of Tokyo Hospital. 1. Presenter: Masaya Sato: Specialized Clinician (Department of Internal Medicine, Gastroenterology), Department of Inspection Dept., University of Tokyo School of Medicine Affiliated Hospital Ryosuke Koseishi: Graduate School of Medicine, University of Tokyo Graduate School of Medicine, Graduate School of Gastroenterological Sciences Guest Lecturer Kazuhiko Koike: Graduate School of Medicine, Kyoto University Professor of Gastroenterology 2. Presentation Points:0 NASH ◆ At the University of Tokyo Medical School Hospital the world'...